Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1561 Inhibitors

Olr1561 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the Olr1561 receptor, which is part of the olfactory receptor family within the broader G-protein coupled receptor (GPCR) superfamily. These receptors are key players in the olfactory system, where they are responsible for detecting and transducing signals from odorant molecules, ultimately contributing to the sense of smell. The Olr1561 receptor functions by binding to specific odorant ligands, which then triggers a cascade of intracellular signaling events. These events result in the activation of neural pathways that convey sensory information to the brain, allowing for the perception of various odors. Inhibitors of Olr1561 are developed to disrupt this signaling process by binding to the receptor in a manner that prevents its natural ligands from activating it. This inhibition can be achieved through competitive binding at the receptor's active site or by interacting with allosteric sites that induce conformational changes, rendering the receptor less capable of functioning effectively.

The development of Olr1561 inhibitors involves a rigorous and systematic approach to optimizing their chemical properties, including binding affinity, selectivity, and stability. Researchers use advanced techniques such as molecular modeling and docking simulations to predict how these inhibitors will interact with the Olr1561 receptor. These computational methods help to identify potential binding sites on the receptor and guide the design of compounds that can effectively inhibit receptor activity. High-throughput screening of chemical libraries is another essential step in discovering lead compounds that exhibit strong inhibitory effects on Olr1561. Once these lead compounds are identified, they undergo structure-activity relationship (SAR) studies, which involve fine-tuning their chemical structures to enhance their potency, selectivity, and overall stability. Modifications might include altering the core chemical scaffold or adjusting functional groups to improve interactions with the receptor while minimizing off-target effects. Additionally, considerations such as solubility, lipophilicity, and metabolic stability are carefully evaluated to ensure that these inhibitors are effective in various physiological conditions. Through this detailed and strategic development process, Olr1561 inhibitors provide valuable insights into the molecular mechanisms of olfactory receptor function and contribute to a broader understanding of GPCR-mediated signal transduction in sensory perception.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR inhibitor, may disrupt signaling cascades intersecting with Olr1561 function.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor, could alter cell growth pathways relevant to Olr1561 activity.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR/HER2 inhibitor, potentially modifies signaling pathways impacting Olr1561.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF kinase inhibitor, might affect MAPK pathway involved in Olr1561 regulation.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-targeted receptor tyrosine kinase inhibitor, could influence pathways related to Olr1561.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

BCR-ABL inhibitor, may modulate signaling cascades relevant to Olr1561 activity.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL inhibitor, potentially disrupts pathways connected to Olr1561 function.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Multi-kinase inhibitor, could affect VEGF signaling and other pathways linked to Olr1561.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

EGFR inhibitor, may interfere with signaling pathways relevant to Olr1561.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Inhibitor of VEGFR, EGFR, and RET kinases, might modulate multiple pathways related to Olr1561.